Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetium Lozenges for Smoking Cessation
NCT02758743Completed
- Sponsor
- Biohit Oyj
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Acetium Lozenge with Placebo (2 arms). Primary endpoints: Prolonged Abstinence at 6 months and Point Prevalence of Abstinence at 6 months. Started Apr 2016; status: completed.
02
Drugs
Acetium
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02758743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758743.